意大利多学科德尔菲共识管理儿童和青少年轻中度急性疼痛。

IF 1 Q3 PEDIATRICS
Michele Miraglia Del Giudice, Gianluigi Marseglia, Francesco Scaglione, Amelia Licari, Giorgio Ciprandi
{"title":"意大利多学科德尔菲共识管理儿童和青少年轻中度急性疼痛。","authors":"Michele Miraglia Del Giudice, Gianluigi Marseglia, Francesco Scaglione, Amelia Licari, Giorgio Ciprandi","doi":"10.23736/S2724-5276.25.07831-0","DOIUrl":null,"url":null,"abstract":"<p><p>Acute pain is a common symptom in children and adolescents. Guidelines recommend measuring pain severity in all subjects using adequate scales. In addition, guidelines recommend always to treat pain. Acetaminophen as pain-reliever and Ibuprofen as NSAID with analgesic effect are extensively considered a first-choice medications for relieving mild-moderate acute pain in children. However, among NSAIDs also ketoprofen lysine salt is indicated in young patients 6 years of age and older and proved to exert analgesic, anti-inflammatory, and antipyretic effects. The present multidisciplinary Delphi Consensus, promoted by the Italian Society of Allergy and Clinical Immunology (SIAIP), aimed at proposing practical statements about pain management and the possible use of ketoprofen lysine salt (KLS) to relieve mild-moderate acute pediatric pain. A multidisciplinary panel of 33 qualified experts discussed and anonymously voted on the statements drafted by a steering committee. The results confirmed a large agreement about the importance of adequately assessing pain severity and treating pain in all children and adolescents. The current multidisciplinary Delphi Consensus advocated constantly measuring pain through algometric scales and treating all children in all situations. The Delphi Consensus also agreed that KLS is effective, rapid, and safe in managing children from the age of six and adolescents with mild-moderate acute pain. As a result, KLS may be a valuable option in this clinical setting. The Delphi Consensus also agreed that KLS may display an efficacy and safety overlapping with ibuprofen and acetaminophen. As a result, KLS may be considered a valuable option in managing children older than six years and adolescents with mild-moderate acute pain.</p>","PeriodicalId":56337,"journal":{"name":"Minerva Pediatrics","volume":" ","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An Italian multidisciplinary Delphi Consensus on managing children and adolescents with mild-moderate acute pain.\",\"authors\":\"Michele Miraglia Del Giudice, Gianluigi Marseglia, Francesco Scaglione, Amelia Licari, Giorgio Ciprandi\",\"doi\":\"10.23736/S2724-5276.25.07831-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Acute pain is a common symptom in children and adolescents. Guidelines recommend measuring pain severity in all subjects using adequate scales. In addition, guidelines recommend always to treat pain. Acetaminophen as pain-reliever and Ibuprofen as NSAID with analgesic effect are extensively considered a first-choice medications for relieving mild-moderate acute pain in children. However, among NSAIDs also ketoprofen lysine salt is indicated in young patients 6 years of age and older and proved to exert analgesic, anti-inflammatory, and antipyretic effects. The present multidisciplinary Delphi Consensus, promoted by the Italian Society of Allergy and Clinical Immunology (SIAIP), aimed at proposing practical statements about pain management and the possible use of ketoprofen lysine salt (KLS) to relieve mild-moderate acute pediatric pain. A multidisciplinary panel of 33 qualified experts discussed and anonymously voted on the statements drafted by a steering committee. The results confirmed a large agreement about the importance of adequately assessing pain severity and treating pain in all children and adolescents. The current multidisciplinary Delphi Consensus advocated constantly measuring pain through algometric scales and treating all children in all situations. The Delphi Consensus also agreed that KLS is effective, rapid, and safe in managing children from the age of six and adolescents with mild-moderate acute pain. As a result, KLS may be a valuable option in this clinical setting. The Delphi Consensus also agreed that KLS may display an efficacy and safety overlapping with ibuprofen and acetaminophen. As a result, KLS may be considered a valuable option in managing children older than six years and adolescents with mild-moderate acute pain.</p>\",\"PeriodicalId\":56337,\"journal\":{\"name\":\"Minerva Pediatrics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2025-06-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Minerva Pediatrics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23736/S2724-5276.25.07831-0\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Pediatrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S2724-5276.25.07831-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

摘要

急性疼痛是儿童和青少年的常见症状。指南建议使用适当的量表测量所有受试者的疼痛严重程度。此外,指南建议总是治疗疼痛。对乙酰氨基酚作为止痛药,布洛芬作为非甾体抗炎药具有镇痛作用,被广泛认为是缓解儿童轻中度急性疼痛的首选药物。然而,在非甾体抗炎药中,酮洛芬赖氨酸盐也适用于6岁及以上的年轻患者,并被证明具有镇痛、抗炎和解热作用。目前,由意大利过敏和临床免疫学学会(SIAIP)推动的多学科德尔菲共识,旨在提出有关疼痛管理和可能使用酮洛芬赖氨酸盐(KLS)缓解轻中度急性儿科疼痛的实用声明。一个由33名合格专家组成的多学科小组对指导委员会起草的声明进行了讨论和匿名投票。结果证实了充分评估疼痛严重程度和治疗所有儿童和青少年疼痛的重要性的很大共识。目前多学科的德尔菲共识主张通过计量量表不断测量疼痛,并在所有情况下治疗所有儿童。德尔菲共识还一致认为,KLS治疗6岁以上儿童和青少年轻中度急性疼痛是有效、快速和安全的。因此,在这种临床环境中,KLS可能是一个有价值的选择。德尔菲共识还一致认为,KLS可能与布洛芬和对乙酰氨基酚表现出疗效和安全性重叠。因此,KLS可能被认为是治疗6岁以上儿童和轻度-中度急性疼痛的青少年的一个有价值的选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
An Italian multidisciplinary Delphi Consensus on managing children and adolescents with mild-moderate acute pain.

Acute pain is a common symptom in children and adolescents. Guidelines recommend measuring pain severity in all subjects using adequate scales. In addition, guidelines recommend always to treat pain. Acetaminophen as pain-reliever and Ibuprofen as NSAID with analgesic effect are extensively considered a first-choice medications for relieving mild-moderate acute pain in children. However, among NSAIDs also ketoprofen lysine salt is indicated in young patients 6 years of age and older and proved to exert analgesic, anti-inflammatory, and antipyretic effects. The present multidisciplinary Delphi Consensus, promoted by the Italian Society of Allergy and Clinical Immunology (SIAIP), aimed at proposing practical statements about pain management and the possible use of ketoprofen lysine salt (KLS) to relieve mild-moderate acute pediatric pain. A multidisciplinary panel of 33 qualified experts discussed and anonymously voted on the statements drafted by a steering committee. The results confirmed a large agreement about the importance of adequately assessing pain severity and treating pain in all children and adolescents. The current multidisciplinary Delphi Consensus advocated constantly measuring pain through algometric scales and treating all children in all situations. The Delphi Consensus also agreed that KLS is effective, rapid, and safe in managing children from the age of six and adolescents with mild-moderate acute pain. As a result, KLS may be a valuable option in this clinical setting. The Delphi Consensus also agreed that KLS may display an efficacy and safety overlapping with ibuprofen and acetaminophen. As a result, KLS may be considered a valuable option in managing children older than six years and adolescents with mild-moderate acute pain.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.50
自引率
0.00%
发文量
294
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信